共 50 条
- [3] Quantitative phosphoproteomic analysis identifies the potential therapeutic target EphA2 for overcoming sorafenib resistance in hepatocellular carcinoma cells [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2020, 52 (03): : 497 - 513
- [4] Quantitative phosphoproteomic analysis identifies the potential therapeutic target EphA2 for overcoming sorafenib resistance in hepatocellular carcinoma cells [J]. Experimental & Molecular Medicine, 2020, 52 : 497 - 513
- [8] PC-3 cells with enhanced androgen receptor signaling: A model for clonal selection in prostate cancer [J]. PROSTATE, 2004, 60 (04): : 352 - 366
- [9] EPHA2: A novel target for prostate cancer treatment [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 482 - 482
- [10] Overexpression of the EphA2 tyrosine kinase in prostate cancer [J]. PROSTATE, 1999, 41 (04): : 275 - 280